Atlas Trials

Melphalan 200 mg/m2 Versus Melphalan 100 mg/m2 in Newly Diagnosed Myeloma Patients

Clinical trial NCT00950768 · COMPLETED

Trial details

NCT number
NCT00950768
Sponsor
Azienda Ospedaliera San Giovanni Battista
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Multiple MyelomaDiagnosis
Start date
2002-02-01
Primary completion
2009-05-01
Enrollment
298

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.